Market News
Latest news from Stock markets.
Defense Stocks Stumble As Iran Conflict Escalates—Lockheed Martin, Palantir, RTX Down
Rosenblatt Securities on Monday increased its price target for Palantir's shares by 33% to $200, joining UBS, HSBC, William Blair and other firms to raise their ratings on the software firm's stock in recent weeks. Rosenblatt cited the Iran conflict and said it believes Palantir's software would be more effective for military use than relying on large language models.
...keep reeding on forbes.com
Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript
Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript
...keep reeding on seekingalpha.com
Can WBD Capitalize on PSKY's Modified Proposal to Drive Value?
Warner Bros. Discovery's board backs PSKY's revised $31-per-share cash bid, citing stronger terms and added deal protections.
...keep reeding on zacks.com
NIO, XPeng & Li Auto Post Delivery Results for February
NIO, XPEV and LI unveil February deliveries, with NIO up 57.6% year over year, XPeng expanding P7+ globally and Li Auto topping 26,000 units.
...keep reeding on zacks.com
Can NetApp's Free Cash Flow Momentum Sustain Shareholder Returns?
NetApp NTAP delivered strong fiscal third quarter results, with profitability and cash flows reinforcing its ability to sustain shareholder returns. While revenue growth was modest, disciplined execution and margin strength translated into healthy free cash flow, supporting buybacks and dividends.
...keep reeding on zacks.com
Why CACI International (CACI) is a Top Stock for the Long-Term
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
...keep reeding on zacks.com
Brokers Suggest Investing in Riot Platforms, Inc. (RIOT): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
...keep reeding on zacks.com
Best Buy (BBY) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Best Buy (BBY) give a sense of how its business performed in the quarter ended January 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
...keep reeding on zacks.com
Is It Worth Investing in Cloudflare (NET) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
...keep reeding on zacks.com
EVgo (EVGO) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for EVgo (EVGO) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
...keep reeding on zacks.com
Wall Street Bulls Look Optimistic About Coupang (CPNG): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
...keep reeding on zacks.com
Compared to Estimates, AutoZone (AZO) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for AutoZone (AZO) give a sense of how its business performed in the quarter ended February 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
...keep reeding on zacks.com
Skyward Specialty Insurance (SKWD) Recently Broke Out Above the 50-Day Moving Average
After reaching an important support level, Skyward Specialty Insurance (SKWD) could be a good stock pick from a technical perspective. SKWD surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.
...keep reeding on zacks.com
Target (TGT) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Target (TGT) give insight into how the company performed in the quarter ended January 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
...keep reeding on zacks.com
Wall Street Bulls Look Optimistic About Okta (OKTA): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
...keep reeding on zacks.com
Thor Industries (THO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Thor Industries (THO) give insight into how the company performed in the quarter ended January 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
...keep reeding on zacks.com
Is It Worth Investing in On Holding (ONON) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
...keep reeding on zacks.com
Compared to Estimates, Viking (VIK) Q4 Earnings: A Look at Key Metrics
The headline numbers for Viking (VIK) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
...keep reeding on zacks.com
Is It Worth Investing in SLB (SLB) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
...keep reeding on zacks.com
Compared to Estimates, L.B. Foster (FSTR) Q4 Earnings: A Look at Key Metrics
The headline numbers for L.B. Foster (FSTR) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
...keep reeding on zacks.com
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
...keep reeding on zacks.com
Is It Worth Investing in GE Vernova (GEV) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
...keep reeding on zacks.com
Brokers Suggest Investing in Costco (COST): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
...keep reeding on zacks.com
Medtronic CFO Thierry Piéton to speak at upcoming investor conferences
GALWAY, Ireland, March 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Thierry Piéton, Medtronic executive vice president and chief financial officer, will participate in fireside chats at the following investor conferences: Barclays 28th Annual Global Healthcare Conference Tuesday, March 10, 2026, at 10:30 a.m. a.m. EST (9:30a.m.
...keep reeding on prnewswire.com
Cineverse Announces Start of Production for Australian Horror Flick Wolf Creek Legacy
The third installment of the international hit horror franchise Wolf Creek sees the return of the menacing Mick Taylor LOS ANGELES, March 3, 2026 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), an entertainment technology company and studio, and Bloody Disgusting, its horror division, have today announced the start of production in South Australia on the third feature film instalment of the worldwide hit horror franchise Wolf Creek - with John Jarratt returning as the menacing Mick Taylor. As previously announced, Cineverse has exclusive North American distribution rights to the film, and is planning a wide theatrical release.
...keep reeding on prnewswire.com
Secure Waste Infrastructure: Still Attractive Thanks To Free Cash Flow
SECURE Waste Infrastructure remains attractively valued, trading at a sustaining free cash flow yield just under 7%. 2025 results show strong free cash flow, with C$1.15/share underlying FCF and leverage at only 1.75x adjusted EBITDA. 2026 guidance targets 4%-10% adjusted EBITDA growth, driven by Waste Management and new water infrastructure projects.
...keep reeding on seekingalpha.com
KVH Industries to Host Fourth Quarter/Year-end Conference Call on March 10, 2026
MIDDLETOWN, R.I., March 03, 2026 (GLOBE NEWSWIRE) -- KVH Industries, Inc. (Nasdaq: KVHI), will announce its financial results for the fourth quarter and fiscal year that ended on December 31, 2025, on Tuesday, March 10, 2026.
...keep reeding on globenewswire.com
NYSE: ORCL: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Oracle Corporation
Did you buy ORCL common stock between June 12, 2025, and December 16, 2025? Affected Oracle Corporation Investor Summary Who: Oracle Corporation (NYSE: ORCL) What: Securities fraud class action lawsuit filed Class Period: June 12, 2025, through December 16, 2025 Deadline to Seek Lead Plaintiff Status: April 6, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's data center capabilities for artificial intelligence infrastructure and capital expenditures.
...keep reeding on globenewswire.com
PLTR, NOC and RTX Forecast – AI and Military in Focus
AI struggles again in the early part of the session, as the war related markets are looking positive in the light of everything that is going on.
...keep reeding on fxempire.com
Why Onto (ONTO) Should Be Considered A Semiconductor Play In 2026
Summary: During a recent episode of The AI Investor Podcast, co-host Eric Bleeker cited Onto Innovation as a smart investment play in 2026.
...keep reeding on 247wallst.com
Defense Stocks: Rockets, Radars, and Record Backlogs
Shares of industry leaders Lockheed Martin NYSE: LMT, RTX Corporation NYSE: RTX, and Northrop Grumman NYSE: NOC have surged, with some reaching new highs on a significant increase in trading volume.
...keep reeding on marketbeat.com
Central bank gold demand drops 82% from 2025 average in January, but sovereign demand base broadens – World Gold Council
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
...keep reeding on kitco.com
Stanley Black & Decker Gains From Business Strength Amid Headwinds
SWK gains from 35% aerospace growth and $2.1B cost savings, but Tools & Outdoor weakness and high debt pose near-term risks.
...keep reeding on zacks.com
Is Keurig's Refreshment Beverage Segment Powering Long-Term Growth?
KDP's U.S. Refreshment Beverages unit is driving strong share gains in energy and hydration, reinforcing earnings stability and long-term growth ambitions.
...keep reeding on zacks.com
Roblox Posts Explosive Revenue Growth, Do Margins Catch Up Next?
Roblox Corporation RBLX ended 2025 with a blockbuster quarter, posting revenues of $1.4 billion in fourth-quarter 2025, up 43% year over year, while bookings surged 63% to $2.2 billion. The standout was not just a single viral hit, but broad-based momentum across regions, age groups and content types.
...keep reeding on zacks.com
US will take action to mitigate spiking oil prices amid Iran conflict: Sec. of State Rubio
== Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. Connect with us: — Facebook: https://www.facebook.com/yahoofinance — X/Twitter: https://x.com/YahooFinance — Instagram: https://www.instagram.com/yahoofinance/ — TikTok: https://www.tiktok.com/@yahoofinance — LinkedIn: https://www.linkedin.com/company/yahoo-finance See the Latest News & Data: https://finance.yahoo.com/ Get the Yahoo Finance App: — iOS (https://apple.co/3Rten0R) — Android (https://bit.ly/3t8UnXO)
...keep reeding on youtube.com
ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enphase Energy, Inc. (“Enphase” or “the Company”) (NASDAQ: ENPH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 20, 2026.
...keep reeding on globenewswire.com
Stealth AI Winner Up 210% in a Year is Quietly Outperforming Chip Stocks
Chip stocks get all the applause in an AI rally, but the quiet money often hides in the plumbing.
...keep reeding on 247wallst.com
AAON: Growth Remains Good, But Not Good Enough
AAON, Inc. reported strong growth in Q4. The company's market positioning remains strong, and BASX continues to benefit from the AI CapEx cycle. Gross margin headwinds could persist until 2027. Underutilization at the Memphis facility, and ERP system implementations, weigh on the margin outlook. The valuation remains too expensive. I estimate AAON to have -20% downside to $85.6.
...keep reeding on seekingalpha.com
Clean Harbors, Inc. (CLH) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Clean Harbors, Inc. (CLH) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
...keep reeding on seekingalpha.com
Kemper Corporation (KMPR) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Kemper Corporation (KMPR) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
...keep reeding on seekingalpha.com
Digital Realty Trust, Inc. (DLR) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Digital Realty Trust, Inc. (DLR) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
...keep reeding on seekingalpha.com
Oxford Square Capital Corp. (OXSQ) Q4 2025 Earnings Call Transcript
Oxford Square Capital Corp. (OXSQ) Q4 2025 Earnings Call Transcript
...keep reeding on seekingalpha.com
OGE Advances Clean Energy and Grid Modernization to Drive Growth
OGE Energy ramps up renewables and plans $7.29B in grid upgrades through 2030, but rising fuel costs and supply-chain woes pose challenges.
...keep reeding on zacks.com
CMS Energy to Benefit From Renewable Expansion & Strategic Investments
CMS ramps up renewables and plans $24 billion in grid investments, but coal-related costs and distributed energy risks could weigh on its growth.
...keep reeding on zacks.com
IonQ Deepens Quantum Capabilities With Strategic M&A Push
IONQ ramps up M&A with Seed Innovations and a $1.8B SkyWater deal to build a vertically integrated, enterprise-grade quantum platform.
...keep reeding on zacks.com
Roche's BTK Drug Fenebrutinib Shines in Multiple Sclerosis Study
RHHBY's fenebrutinib slashes RMS relapses by 51% in phase III, advancing its bid for a first high-efficacy oral therapy in MS.
...keep reeding on zacks.com
RYAAY Expands Alicante Presence With New Routes and Capacity Expansion
Ryanair boosts Alicante capacity 10% for Summer 2026 with three new routes and 40 frequency hikes, and aims to capture leisure demand and scale.
...keep reeding on zacks.com
Is Kimberly-Clark Reshaping Its Cost Structure Through Productivity?
KMB leans on productivity gains to counter pricing and tariff pressures, reshaping its cost structure under a sweeping transformation plan.
...keep reeding on zacks.com
PTC Expands Onshape With Advanced Cloud-Native MBD Features
PTC launches cloud-native MBD in Onshape, embedding manufacturing data into 3D models to streamline design, boost collaboration and speed production.
...keep reeding on zacks.com
GE Vernova: More Gigawatts Needed To Fuel AI, Raising My Price Target
GE Vernova remains a "Buy," with a raised price target and strong technical momentum following robust Q4 results and 2026 guidance. Q4 saw GAAP EPS of $13.39 (boosted by tax benefit), $11 billion in revenue (+4% YoY), 65% organic order growth, and doubled free cash flow. The 2026 outlook calls for $44–$45 billion in revenue, $5–$5.5 billion in FCF, and continued margin expansion, targeting a 20% adjusted EBITDA margin by 2028.
...keep reeding on seekingalpha.com